Clonal remission in childhood acute myeloid leukemia is an infrequent event.
Acute myeloid leukemia (AML) is a heterogeneous group of diseases that differ in pattern of both remission and lineage involvement. The observation that hematopoiesis remains clonal in some patients with AML in complete clinical remission suggests that the acute phase may develop from a clinically unrecognized preleukemic clone. To investigate the characteristics and significance of clonal remissions in childhood AML, we used X-chromosome-linked polymorphisms to study granulocytes obtained from pediatric female patients in complete clinical remission. Remission granulocytes from only one of 17 evaluable patients were clonally derived, suggesting that clonal remission is an infrequent event in childhood AML.
Smith
F O
FO
Division of Pediatric Oncology, Fred Hutchinson Cancer Research Center, Seattle, WA 98104.
Raskind
W H
WH
Waldron
P
P
Steinmann
L J
LJ
Matsushita
M
M
Singer
J W
JW
Lampkin
B C
BC
Woods
W G
WG
Lange
B J
BJ
Hammond
G D
GD
D000208:Acute Disease; D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D002999:Clone Cells; D005260:Female; D006410:Hematopoiesis; D006801:Humans; D007041:Hypoxanthine Phosphoribosyltransferase / Q000235:genetics; D007223:Infant; D007951:Leukemia, Myeloid / Q000473:pathology*; D010735:Phosphoglycerate Kinase / Q000235:genetics; D012150:Polymorphism, Restriction Fragment Length
D007041:Hypoxanthine Phosphoribosyltransferase; D010735:Phosphoglycerate Kinase